Plain-English translation of ·
This trial is comparing two different treatment combinations for men with advanced prostate cancer that still responds to hormone therapy. One approach uses three medications together (hormone therapy plus docetaxel, a chemotherapy drug), while the other uses two medications (hormone therapy alone). Researchers want to understand which approach works better and which patients tolerate each treatment best.
Doctors currently recommend using three medications together for this type of advanced prostate cancer, but this three-drug combination has never been directly compared to using just two medications. This study will help doctors and patients make better-informed treatment decisions in the future.
You likely qualify if…
You likely don't qualify if…
You will receive one of the two treatment approaches as decided by you and your doctor—there is no random assignment. Researchers will follow you over time, collecting information about how you respond to treatment, any side effects you experience, and your overall health. Your doctors will use information from your medical records and national health registries to match you with other patients receiving the same treatment, so they can fairly compare how well each approach works.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Sweden